Research programme: Cannabidiol therapeutics - PhytecsAlternative Names: 4'-F-CBD; Fluorinated cannabidiol; HUF 101; HUF 102; HUF 103
Latest Information Update: 01 Mar 2017
At a glance
- Originator Universidade Federal do Rio Grande do Sul; University of Sao Paulo; Yissum Research Development Company
- Class Cannabinoids
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Anxiety disorders; Depressive disorders; Obsessive-compulsive disorders; Psychotic disorders